HNF1B deletions in patients with young-onset diabetes but no known renal disease

Diabet. Med. 30, 114–117 (2013) Aims  Hepatocyte nuclear factor 1β (HNF1B) mutations cause a syndrome of renal cysts and diabetes, with whole gene deletions accounting for approximately 50% of cases. The severity of the renal phenotype is variable, from enlarged cystic kidneys incompatible with life...

Full description

Saved in:
Bibliographic Details
Published inDiabetic medicine Vol. 30; no. 1; pp. 114 - 117
Main Authors Edghill, E. L., Stals, K., Oram, R. A., Shepherd, M. H., Hattersley, A. T., Ellard, S.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.01.2013
Blackwell
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0742-3071
1464-5491
1464-5491
DOI10.1111/j.1464-5491.2012.03709.x

Cover

Abstract Diabet. Med. 30, 114–117 (2013) Aims  Hepatocyte nuclear factor 1β (HNF1B) mutations cause a syndrome of renal cysts and diabetes, with whole gene deletions accounting for approximately 50% of cases. The severity of the renal phenotype is variable, from enlarged cystic kidneys incompatible with life to normal renal development and function. We investigated the prevalence of HNF1B deletions in patients with diabetes but no known renal disease. Methods  We tested 461 patients with familial diabetes diagnosed before 45 years, including 258 probands who met clinical criteria for maturity‐onset diabetes of the young (two generations affected and at least one family member diagnosed under 25 years). A fluorescent polymerase chain reaction assay was used to analyse two intragenic polymorphic HNF1B markers and identify heterozygous patients who therefore did not have whole gene deletions. Those patients homozygous for both markers were then tested for an HNF1B deletion using multiplex ligation‐dependent probe amplification. Results  Heterozygous HNF1B intragenic polymorphisms were identified in 337/461 subjects. Multiplex ligation‐dependent probe amplification analysis showed an HNF1B gene deletion in three of the remaining 124 probands, all of whom met the criteria for maturity‐onset diabetes of the young. Testing of their relatives identified three additional deletion carriers and ultrasound scanning showed renal developmental abnormalities in three of these six patients. Conclusions  We estimate that HNF1B mutations account for < 1% of cases of maturity‐onset diabetes of the young. Although HNF1B mutations are a rare cause of diabetes in the absence of known renal disease, a genetic diagnosis of renal cysts and diabetes syndrome is important as it raises the possibility of subclinical renal disease and the 50% risk of renal cysts and diabetes syndrome in the patient’s offspring.
AbstractList Diabet. Med. 30, 114–117 (2013) Aims  Hepatocyte nuclear factor 1β (HNF1B) mutations cause a syndrome of renal cysts and diabetes, with whole gene deletions accounting for approximately 50% of cases. The severity of the renal phenotype is variable, from enlarged cystic kidneys incompatible with life to normal renal development and function. We investigated the prevalence of HNF1B deletions in patients with diabetes but no known renal disease. Methods  We tested 461 patients with familial diabetes diagnosed before 45 years, including 258 probands who met clinical criteria for maturity‐onset diabetes of the young (two generations affected and at least one family member diagnosed under 25 years). A fluorescent polymerase chain reaction assay was used to analyse two intragenic polymorphic HNF1B markers and identify heterozygous patients who therefore did not have whole gene deletions. Those patients homozygous for both markers were then tested for an HNF1B deletion using multiplex ligation‐dependent probe amplification. Results  Heterozygous HNF1B intragenic polymorphisms were identified in 337/461 subjects. Multiplex ligation‐dependent probe amplification analysis showed an HNF1B gene deletion in three of the remaining 124 probands, all of whom met the criteria for maturity‐onset diabetes of the young. Testing of their relatives identified three additional deletion carriers and ultrasound scanning showed renal developmental abnormalities in three of these six patients. Conclusions  We estimate that HNF1B mutations account for < 1% of cases of maturity‐onset diabetes of the young. Although HNF1B mutations are a rare cause of diabetes in the absence of known renal disease, a genetic diagnosis of renal cysts and diabetes syndrome is important as it raises the possibility of subclinical renal disease and the 50% risk of renal cysts and diabetes syndrome in the patient’s offspring.
Hepatocyte nuclear factor 1β (HNF1B) mutations cause a syndrome of renal cysts and diabetes, with whole gene deletions accounting for approximately 50% of cases. The severity of the renal phenotype is variable, from enlarged cystic kidneys incompatible with life to normal renal development and function. We investigated the prevalence of HNF1B deletions in patients with diabetes but no known renal disease. We tested 461 patients with familial diabetes diagnosed before 45 years, including 258 probands who met clinical criteria for maturity-onset diabetes of the young (two generations affected and at least one family member diagnosed under 25 years). A fluorescent polymerase chain reaction assay was used to analyse two intragenic polymorphic HNF1B markers and identify heterozygous patients who therefore did not have whole gene deletions. Those patients homozygous for both markers were then tested for an HNF1B deletion using multiplex ligation-dependent probe amplification. Heterozygous HNF1B intragenic polymorphisms were identified in 337/461 subjects. Multiplex ligation-dependent probe amplification analysis showed an HNF1B gene deletion in three of the remaining 124 probands, all of whom met the criteria for maturity-onset diabetes of the young. Testing of their relatives identified three additional deletion carriers and ultrasound scanning showed renal developmental abnormalities in three of these six patients. We estimate that HNF1B mutations account for < 1% of cases of maturity-onset diabetes of the young. Although HNF1B mutations are a rare cause of diabetes in the absence of known renal disease, a genetic diagnosis of renal cysts and diabetes syndrome is important as it raises the possibility of subclinical renal disease and the 50% risk of renal cysts and diabetes syndrome in the patient's offspring.
Hepatocyte nuclear factor 1β (HNF1B) mutations cause a syndrome of renal cysts and diabetes, with whole gene deletions accounting for approximately 50% of cases. The severity of the renal phenotype is variable, from enlarged cystic kidneys incompatible with life to normal renal development and function. We investigated the prevalence of HNF1B deletions in patients with diabetes but no known renal disease.AIMSHepatocyte nuclear factor 1β (HNF1B) mutations cause a syndrome of renal cysts and diabetes, with whole gene deletions accounting for approximately 50% of cases. The severity of the renal phenotype is variable, from enlarged cystic kidneys incompatible with life to normal renal development and function. We investigated the prevalence of HNF1B deletions in patients with diabetes but no known renal disease.We tested 461 patients with familial diabetes diagnosed before 45 years, including 258 probands who met clinical criteria for maturity-onset diabetes of the young (two generations affected and at least one family member diagnosed under 25 years). A fluorescent polymerase chain reaction assay was used to analyse two intragenic polymorphic HNF1B markers and identify heterozygous patients who therefore did not have whole gene deletions. Those patients homozygous for both markers were then tested for an HNF1B deletion using multiplex ligation-dependent probe amplification.METHODSWe tested 461 patients with familial diabetes diagnosed before 45 years, including 258 probands who met clinical criteria for maturity-onset diabetes of the young (two generations affected and at least one family member diagnosed under 25 years). A fluorescent polymerase chain reaction assay was used to analyse two intragenic polymorphic HNF1B markers and identify heterozygous patients who therefore did not have whole gene deletions. Those patients homozygous for both markers were then tested for an HNF1B deletion using multiplex ligation-dependent probe amplification.Heterozygous HNF1B intragenic polymorphisms were identified in 337/461 subjects. Multiplex ligation-dependent probe amplification analysis showed an HNF1B gene deletion in three of the remaining 124 probands, all of whom met the criteria for maturity-onset diabetes of the young. Testing of their relatives identified three additional deletion carriers and ultrasound scanning showed renal developmental abnormalities in three of these six patients.RESULTSHeterozygous HNF1B intragenic polymorphisms were identified in 337/461 subjects. Multiplex ligation-dependent probe amplification analysis showed an HNF1B gene deletion in three of the remaining 124 probands, all of whom met the criteria for maturity-onset diabetes of the young. Testing of their relatives identified three additional deletion carriers and ultrasound scanning showed renal developmental abnormalities in three of these six patients.We estimate that HNF1B mutations account for < 1% of cases of maturity-onset diabetes of the young. Although HNF1B mutations are a rare cause of diabetes in the absence of known renal disease, a genetic diagnosis of renal cysts and diabetes syndrome is important as it raises the possibility of subclinical renal disease and the 50% risk of renal cysts and diabetes syndrome in the patient's offspring.CONCLUSIONSWe estimate that HNF1B mutations account for < 1% of cases of maturity-onset diabetes of the young. Although HNF1B mutations are a rare cause of diabetes in the absence of known renal disease, a genetic diagnosis of renal cysts and diabetes syndrome is important as it raises the possibility of subclinical renal disease and the 50% risk of renal cysts and diabetes syndrome in the patient's offspring.
Diabet. Med. 30, 114-117 (2013) Aims Hepatocyte nuclear factor1[beta] (HNF1B) mutations cause a syndrome of renal cysts and diabetes, with whole gene deletions accounting for approximately 50% of cases. The severity of the renal phenotype is variable, from enlarged cystic kidneys incompatible with life to normal renal development and function. We investigated the prevalence of HNF1B deletions in patients with diabetes but no known renal disease. Methods We tested 461 patients with familial diabetes diagnosed before 45years, including 258 probands who met clinical criteria for maturity-onset diabetes of the young (two generations affected and at least one family member diagnosed under 25years). A fluorescent polymerase chain reaction assay was used to analyse two intragenic polymorphic HNF1B markers and identify heterozygous patients who therefore did not have whole gene deletions. Those patients homozygous for both markers were then tested for an HNF1B deletion using multiplex ligation-dependent probe amplification. Results Heterozygous HNF1B intragenic polymorphisms were identified in 337/461 subjects. Multiplex ligation-dependent probe amplification analysis showed an HNF1B gene deletion in three of the remaining 124 probands, all of whom met the criteria for maturity-onset diabetes of the young. Testing of their relatives identified three additional deletion carriers and ultrasound scanning showed renal developmental abnormalities in three of these six patients. Conclusions We estimate that HNF1B mutations account for <1% of cases of maturity-onset diabetes of the young. Although HNF1B mutations are a rare cause of diabetes in the absence of known renal disease, a genetic diagnosis of renal cysts and diabetes syndrome is important as it raises the possibility of subclinical renal disease and the 50% risk of renal cysts and diabetes syndrome in the patient's offspring. [PUBLICATION ABSTRACT]
Author Edghill, E. L.
Shepherd, M. H.
Oram, R. A.
Hattersley, A. T.
Ellard, S.
Stals, K.
Author_xml – sequence: 1
  givenname: E. L.
  surname: Edghill
  fullname: Edghill, E. L.
  organization: Institute of Biomedical and Clinical Science, Peninsula Medical School, University of Exeter
– sequence: 2
  givenname: K.
  surname: Stals
  fullname: Stals, K.
  organization: Department of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
– sequence: 3
  givenname: R. A.
  surname: Oram
  fullname: Oram, R. A.
  organization: Institute of Biomedical and Clinical Science, Peninsula Medical School, University of Exeter
– sequence: 4
  givenname: M. H.
  surname: Shepherd
  fullname: Shepherd, M. H.
  organization: Institute of Biomedical and Clinical Science, Peninsula Medical School, University of Exeter
– sequence: 5
  givenname: A. T.
  surname: Hattersley
  fullname: Hattersley, A. T.
  organization: Institute of Biomedical and Clinical Science, Peninsula Medical School, University of Exeter
– sequence: 6
  givenname: S.
  surname: Ellard
  fullname: Ellard, S.
  organization: Institute of Biomedical and Clinical Science, Peninsula Medical School, University of Exeter
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26732533$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22587559$$D View this record in MEDLINE/PubMed
BookMark eNqNkU9v0zAYhy00xLrBV0CWEBKXZP4bxweQtrFuSKNwAHq0nNQGd6lTbEdtvz3O2g1pp_liS-_zvLbf3wk48r03AECMSpzX2bLErGIFZxKXBGFSIiqQLLcvwOSxcAQmSDBSUCTwMTiJcYkyKal8BY4J4bXgXE7A95vZFF_AhelMcr2P0Hm41skZnyLcuPQH7vrB_y5yySS4cLoxyUTYDAn6Ht75fuNhMF53uRaNjuY1eGl1F82bw34Kfk6vflzeFLffrr9cnt8WLcdcFhojZGtJEeWYSstqIk3LBbNVK6xdMMEpr62oJaaaCYGZaFBV8aa2WcBY01PwYd93Hfq_g4lJrVxsTddpb_ohKkwYIphXnGf03RN02Q8hv3mkaJ3nQ2uWqbcHamhWZqHWwa102KmHWWXg_QHQsdWdDdq3Lv7nKkEJpzRzn_ZcG_oYg7GqdUmP001Bu05hpMYQ1VKNWakxKzWGqO5DVNvcoH7S4OGOZ6gf9-rGdWb3bE99_no1nrJf7H0Xk9k--jrcqfw9wdV8dq3m0_l0dvGLK0L_AZtQvsc
CODEN DIMEEV
CitedBy_id crossref_primary_10_1007_s00467_013_2662_x
crossref_primary_10_1186_s12902_018_0257_z
crossref_primary_10_1007_s00125_013_2962_5
crossref_primary_10_1016_S0929_693X_13_71315_0
crossref_primary_10_1007_s40472_014_0042_5
crossref_primary_10_4093_jkd_2022_23_3_157
crossref_primary_10_2337_db15_1666
crossref_primary_10_1080_07435800_2024_2388606
crossref_primary_10_1172_JCI142244
crossref_primary_10_1111_nep_12199
crossref_primary_10_36485_1561_6274_2020_24_3_54_63
crossref_primary_10_1007_s00592_021_01794_8
crossref_primary_10_1038_s41572_019_0109_9
crossref_primary_10_1016_j_jmoldx_2013_03_006
crossref_primary_10_1111_cen_12541
crossref_primary_10_1111_ahg_12093
crossref_primary_10_1016_j_diabres_2014_03_008
crossref_primary_10_1038_ejhg_2014_14
crossref_primary_10_2337_dc21_1975
crossref_primary_10_3390_ijms232112910
crossref_primary_10_1007_s00467_015_3142_2
crossref_primary_10_1186_s12916_019_1363_0
crossref_primary_10_1007_s13410_024_01319_3
crossref_primary_10_1002_mgg3_962
crossref_primary_10_1210_clinem_dgaa613
crossref_primary_10_3390_ijms25189823
crossref_primary_10_1038_nrneph_2014_232
crossref_primary_10_20945_2359_3997000000138
crossref_primary_10_4158_ACCR_2020_0161
crossref_primary_10_1210_er_2015_1116
crossref_primary_10_1007_s13353_024_00907_7
crossref_primary_10_1038_s43856_023_00369_8
crossref_primary_10_1111_1753_0407_12043
crossref_primary_10_2337_db19_0510
Cites_doi 10.1681/ASN.2008060633
10.1111/j.1464-5491.2006.01999.x
10.1530/EJE-08-0203
10.1093/ndt/gfh348
10.1093/hmg/ddg355
10.2337/diacare.27.5.1102
10.1086/522591
10.7326/0003-4819-140-7-200404060-00009
10.1111/j.1464-5491.2008.02460.x
10.1681/ASN.2006030277
10.1038/ng1297-384
10.2337/diabetes.54.11.3126
10.1093/ndt/gfm603
10.2215/CJN.06810909
10.1046/j.1523-1755.2000.057003898.x
ContentType Journal Article
Copyright 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK
2014 INIST-CNRS
2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
Copyright_xml – notice: 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK
– notice: 2014 INIST-CNRS
– notice: 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1111/j.1464-5491.2012.03709.x
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Nursing
EISSN 1464-5491
EndPage 117
ExternalDocumentID 2840905581
22587559
26732533
10_1111_j_1464_5491_2012_03709_x
DME3709
ark_67375_WNG_WFWFNBV5_2
Genre shortCommunication
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: Department of Health
  grantid: PDA/02/06/098
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1OB
1OC
29F
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIAGR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
V8K
V9Y
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
XV2
YFH
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAHHS
ACCFJ
ADZOD
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
ESX
RWI
WRC
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
8FD
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c5159-a100f893035139f4829ec574f6c7ffd475358f78913a477147b0665b8f35111a3
IEDL.DBID DR2
ISSN 0742-3071
1464-5491
IngestDate Fri Sep 05 14:14:21 EDT 2025
Fri Jul 25 03:55:47 EDT 2025
Mon Jul 21 05:20:10 EDT 2025
Wed Apr 02 07:49:42 EDT 2025
Tue Jul 01 00:56:47 EDT 2025
Thu Apr 24 23:13:10 EDT 2025
Wed Jan 22 16:19:21 EST 2025
Tue Sep 09 05:32:13 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Endocrinopathy
Human
Kidney disease
Maturity onset diabetes young
Obesity
Urinary system disease
Nutrition
Nutrition disorder
Patient
Metabolic diseases
Genetic disease
Nephropathy
Deletion
Endocrinology
Nutritional status
Language English
License CC BY 4.0
2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5159-a100f893035139f4829ec574f6c7ffd475358f78913a477147b0665b8f35111a3
Notes ark:/67375/WNG-WFWFNBV5-2
istex:F37205F4FE87C36A59D7373CC959F9E6907A1E0D
ArticleID:DME3709
These authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://zenodo.org/record/3436753
PMID 22587559
PQID 1238071384
PQPubID 1006515
PageCount 4
ParticipantIDs proquest_miscellaneous_1240215655
proquest_journals_1238071384
pubmed_primary_22587559
pascalfrancis_primary_26732533
crossref_citationtrail_10_1111_j_1464_5491_2012_03709_x
crossref_primary_10_1111_j_1464_5491_2012_03709_x
wiley_primary_10_1111_j_1464_5491_2012_03709_x_DME3709
istex_primary_ark_67375_WNG_WFWFNBV5_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-01
January 2013
2013-01-00
2013
2013-Jan
20130101
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – month: 01
  year: 2013
  text: 2013-01
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
– name: London
PublicationTitle Diabetic medicine
PublicationTitleAlternate Diabet Med
PublicationYear 2013
Publisher Blackwell Publishing Ltd
Blackwell
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell
– name: Wiley Subscription Services, Inc
References Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN et al.Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat Genet1997; 17: 384-385.
Edghill EL, Oram RA, Owens M, Stals KL, Harries LW, Hattersley AT et al.Hepatocyte nuclear factor-1beta gene deletions-a common cause of renal disease. Nephrol Dial Transplant2008; 23: 627-635.
Haldorsen IS, Vesterhus M, Raeder H, Jensen DK, Sovik O, Molven A et al.Lack of pancreatic body and tail in HNF1B mutation carriers. Diabet Med2008; 25: 782-787.
Pearson ER, Badman MK, Lockwood CR, Clark PM, Ellard S, Bingham C et al.Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1α and -1β mutations. Diabetes Care2004; 27: 1102-1107.
Bellanne-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C et al.Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes2005; 54: 3126-3132.
Mefford HC, Clauin S, Sharp AJ, Moller RS, Ullmann R, Kapur R et al.Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy. Am J Hum Genet2007; 81: 1057-1069.
Bingham C, Ellard S, Allen L, Bulman M, Shepherd M, Frayling T et al.Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta. Kidney Int2000; 57: 898-907.
Bellanne-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S et al.Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med2004; 140: 510-517.
Edghill E, Owens M, Harries LW, Bingham C, Ellard S, Hattersley AT. Hepatocyte nuclear factor-1β gene deletions are common in subjects with unexplained renal disease and diabetes. Diabet Med2006; 23: 41.
Heidet L, Decramer S, Pawtowski A, Moriniere V, Bandin F, Knebelmann B et al.Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. Clin J Am Soc Nephrol2010; 5: 1079-1090.
Edghill EL, Bingham C, Slingerland AS, Minton JA, Noordam C, Ellard S et al.Hepatocyte nuclear factor-1β mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1β in human pancreatic development. Diabet Med2006; 23: 1301-1306.
Weber S, Moriniere V, Knuppel T, Charbit M, Dusek J, Ghiggeri GM et al.Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J Am Soc Nephrol2006; 17: 2864-2870.
Adalat S, Woolf AS, Johnstone KA, Wirsing A, Harries LW, Long DA et al. HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol2009; 20: 1123-1131.
Christesen HB, Tribble ND, Molven A, Siddiqui J, Sandal T, Brusgaard K et al.Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation. Eur J Endocrinol2008; 159: 27-34.
Chen YZ, Gao Q, Zhao XZ, Bennett CL, Xiong XS, Mei CL et al.Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5. Chinese Med J2010; 123: 3326-3333.
Bingham C, Hattersley AT. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. Nephrol Dial Transplant2004; 19: 2703-2708.
Maestro MA, Boj SF, Luco RF, Pierreux CE, Cabedo J, Servitja JM et al.Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas. Hum Mol Genet2003; 12: 3307-3314.
2009; 20
2006; 23
2004; 19
2004; 27
2000; 57
2004; 140
2006; 17
2010; 123
2008; 25
1997; 17
2008; 23
2005; 54
2007; 81
2008; 159
2010; 5
2003; 12
Chen YZ (e_1_2_8_3_2) 2010; 123
e_1_2_8_16_2
e_1_2_8_17_2
Edghill E (e_1_2_8_6_2) 2006; 23
e_1_2_8_18_2
e_1_2_8_12_2
e_1_2_8_13_2
e_1_2_8_14_2
e_1_2_8_15_2
e_1_2_8_9_2
e_1_2_8_2_2
e_1_2_8_4_2
e_1_2_8_5_2
e_1_2_8_8_2
e_1_2_8_7_2
e_1_2_8_10_2
e_1_2_8_11_2
References_xml – reference: Pearson ER, Badman MK, Lockwood CR, Clark PM, Ellard S, Bingham C et al.Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1α and -1β mutations. Diabetes Care2004; 27: 1102-1107.
– reference: Bellanne-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C et al.Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes2005; 54: 3126-3132.
– reference: Christesen HB, Tribble ND, Molven A, Siddiqui J, Sandal T, Brusgaard K et al.Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation. Eur J Endocrinol2008; 159: 27-34.
– reference: Mefford HC, Clauin S, Sharp AJ, Moller RS, Ullmann R, Kapur R et al.Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy. Am J Hum Genet2007; 81: 1057-1069.
– reference: Weber S, Moriniere V, Knuppel T, Charbit M, Dusek J, Ghiggeri GM et al.Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J Am Soc Nephrol2006; 17: 2864-2870.
– reference: Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN et al.Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat Genet1997; 17: 384-385.
– reference: Bellanne-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S et al.Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med2004; 140: 510-517.
– reference: Haldorsen IS, Vesterhus M, Raeder H, Jensen DK, Sovik O, Molven A et al.Lack of pancreatic body and tail in HNF1B mutation carriers. Diabet Med2008; 25: 782-787.
– reference: Edghill E, Owens M, Harries LW, Bingham C, Ellard S, Hattersley AT. Hepatocyte nuclear factor-1β gene deletions are common in subjects with unexplained renal disease and diabetes. Diabet Med2006; 23: 41.
– reference: Edghill EL, Oram RA, Owens M, Stals KL, Harries LW, Hattersley AT et al.Hepatocyte nuclear factor-1beta gene deletions-a common cause of renal disease. Nephrol Dial Transplant2008; 23: 627-635.
– reference: Heidet L, Decramer S, Pawtowski A, Moriniere V, Bandin F, Knebelmann B et al.Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. Clin J Am Soc Nephrol2010; 5: 1079-1090.
– reference: Adalat S, Woolf AS, Johnstone KA, Wirsing A, Harries LW, Long DA et al. HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol2009; 20: 1123-1131.
– reference: Bingham C, Ellard S, Allen L, Bulman M, Shepherd M, Frayling T et al.Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta. Kidney Int2000; 57: 898-907.
– reference: Maestro MA, Boj SF, Luco RF, Pierreux CE, Cabedo J, Servitja JM et al.Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas. Hum Mol Genet2003; 12: 3307-3314.
– reference: Edghill EL, Bingham C, Slingerland AS, Minton JA, Noordam C, Ellard S et al.Hepatocyte nuclear factor-1β mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1β in human pancreatic development. Diabet Med2006; 23: 1301-1306.
– reference: Chen YZ, Gao Q, Zhao XZ, Bennett CL, Xiong XS, Mei CL et al.Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5. Chinese Med J2010; 123: 3326-3333.
– reference: Bingham C, Hattersley AT. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. Nephrol Dial Transplant2004; 19: 2703-2708.
– volume: 5
  start-page: 1079
  year: 2010
  end-page: 1090
  article-title: Spectrum of mutations in a large cohort of patients who harbor renal diseases
  publication-title: Clin J Am Soc Nephrol
– volume: 12
  start-page: 3307
  year: 2003
  end-page: 3314
  article-title: Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas
  publication-title: Hum Mol Genet
– volume: 17
  start-page: 384
  year: 1997
  end-page: 385
  article-title: Mutation in hepatocyte nuclear factor‐1β gene (TCF2) associated with MODY
  publication-title: Nat Genet
– volume: 19
  start-page: 2703
  year: 2004
  end-page: 2708
  article-title: Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor‐1beta
  publication-title: Nephrol Dial Transplant
– volume: 81
  start-page: 1057
  year: 2007
  end-page: 1069
  article-title: Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy
  publication-title: Am J Hum Genet
– volume: 23
  start-page: 627
  year: 2008
  end-page: 635
  article-title: Hepatocyte nuclear factor‐1beta gene deletions—a common cause of renal disease
  publication-title: Nephrol Dial Transplant
– volume: 140
  start-page: 510
  year: 2004
  end-page: 517
  article-title: Clinical spectrum associated with hepatocyte nuclear factor‐1beta mutations
  publication-title: Ann Intern Med
– volume: 17
  start-page: 2864
  year: 2006
  end-page: 2870
  article-title: Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study
  publication-title: J Am Soc Nephrol
– volume: 159
  start-page: 27
  year: 2008
  end-page: 34
  article-title: Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation
  publication-title: Eur J Endocrinol
– volume: 123
  start-page: 3326
  year: 2010
  end-page: 3333
  article-title: Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5
  publication-title: Chinese Med J
– volume: 54
  start-page: 3126
  year: 2005
  end-page: 3132
  article-title: Large genomic rearrangements in the hepatocyte nuclear factor‐1beta (TCF2) gene are the most frequent cause of maturity‐onset diabetes of the young type 5
  publication-title: Diabetes
– volume: 23
  start-page: 41
  year: 2006
  article-title: Hepatocyte nuclear factor‐1β gene deletions are common in subjects with unexplained renal disease and diabetes
  publication-title: Diabet Med
– volume: 57
  start-page: 898
  year: 2000
  end-page: 907
  article-title: Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor‐1 beta
  publication-title: Kidney Int
– volume: 27
  start-page: 1102
  year: 2004
  end-page: 1107
  article-title: Contrasting diabetes phenotypes associated with hepatocyte nuclear factor‐1α and ‐1β mutations
  publication-title: Diabetes Care
– volume: 23
  start-page: 1301
  year: 2006
  end-page: 1306
  article-title: Hepatocyte nuclear factor‐1β mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF‐1β in human pancreatic development
  publication-title: Diabet Med
– volume: 25
  start-page: 782
  year: 2008
  end-page: 787
  article-title: Lack of pancreatic body and tail in HNF1B mutation carriers
  publication-title: Diabet Med
– volume: 20
  start-page: 1123
  year: 2009
  end-page: 1131
  article-title: mutations associate with hypomagnesemia and renal magnesium wasting
  publication-title: J Am Soc Nephrol
– volume: 123
  start-page: 3326
  year: 2010
  ident: e_1_2_8_3_2
  article-title: Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5
  publication-title: Chinese Med J
– ident: e_1_2_8_12_2
  doi: 10.1681/ASN.2008060633
– ident: e_1_2_8_8_2
  doi: 10.1111/j.1464-5491.2006.01999.x
– ident: e_1_2_8_16_2
  doi: 10.1530/EJE-08-0203
– ident: e_1_2_8_9_2
  doi: 10.1093/ndt/gfh348
– ident: e_1_2_8_17_2
  doi: 10.1093/hmg/ddg355
– volume: 23
  start-page: 41
  year: 2006
  ident: e_1_2_8_6_2
  article-title: Hepatocyte nuclear factor‐1β gene deletions are common in subjects with unexplained renal disease and diabetes
  publication-title: Diabet Med
– ident: e_1_2_8_18_2
  doi: 10.2337/diacare.27.5.1102
– ident: e_1_2_8_5_2
  doi: 10.1086/522591
– ident: e_1_2_8_10_2
  doi: 10.7326/0003-4819-140-7-200404060-00009
– ident: e_1_2_8_11_2
  doi: 10.1111/j.1464-5491.2008.02460.x
– ident: e_1_2_8_15_2
  doi: 10.1681/ASN.2006030277
– ident: e_1_2_8_2_2
  doi: 10.1038/ng1297-384
– ident: e_1_2_8_4_2
  doi: 10.2337/diabetes.54.11.3126
– ident: e_1_2_8_7_2
  doi: 10.1093/ndt/gfm603
– ident: e_1_2_8_14_2
  doi: 10.2215/CJN.06810909
– ident: e_1_2_8_13_2
  doi: 10.1046/j.1523-1755.2000.057003898.x
SSID ssj0012939
Score 2.2514527
Snippet Diabet. Med. 30, 114–117 (2013) Aims  Hepatocyte nuclear factor 1β (HNF1B) mutations cause a syndrome of renal cysts and diabetes, with whole gene deletions...
Hepatocyte nuclear factor 1β (HNF1B) mutations cause a syndrome of renal cysts and diabetes, with whole gene deletions accounting for approximately 50% of...
Diabet. Med. 30, 114-117 (2013) Aims Hepatocyte nuclear factor1[beta] (HNF1B) mutations cause a syndrome of renal cysts and diabetes, with whole gene deletions...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 114
SubjectTerms Adolescent
Adult
Biological and medical sciences
Child
Child, Preschool
Cysts
Diabetes
Diabetes Mellitus, Type 2 - genetics
Diabetes. Impaired glucose tolerance
Diabetic Nephropathies - genetics
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Feeding. Feeding behavior
Female
Fundamental and applied biological sciences. Psychology
Gene Deletion
Genetic Testing
Hepatocyte Nuclear Factor 1-beta - genetics
Homozygote
Humans
Infant
Kidney Diseases, Cystic - genetics
Male
Medical research
Medical sciences
Middle Aged
Mutation
Polymorphism, Genetic - genetics
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Vertebrates: endocrinology
Young Adult
Title HNF1B deletions in patients with young-onset diabetes but no known renal disease
URI https://api.istex.fr/ark:/67375/WNG-WFWFNBV5-2/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-5491.2012.03709.x
https://www.ncbi.nlm.nih.gov/pubmed/22587559
https://www.proquest.com/docview/1238071384
https://www.proquest.com/docview/1240215655
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0742-3071
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1464-5491
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0012939
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fa9swED9KR8deuq3bOm9dUWHszSG2JEt-XP94oZA8lHXpm5AcC0qKMxIH2j3tI-wz7pNMJyseLn0oY2-G-Gx0OZ1-97vzHcBHKZ1fpCaPKyvLmDn_F5uhpTGjM2aYlZrOkBoYT7LRJTu_4leh_gm_hWn7Q3SEG-4M769xg2uzur_JWeziGwzzkNKjYpgPEE8mlPuM7UXXSQpPtbztyJki3ZL0i3oefFDvpHqCSr_Fykm9csqz7dSLh2BpH-X6Y6p4DvPNAtvqlPlg3ZhB-eNe78f_o4EXsBvQLPncmt9L2KrqPXg6Dvn6PdgJZMQruBhNiuSY4Ngdb-nkuiahp-uKIBlM7tDv_P75C8u7G7LhhIlZN6ReEOT-arKs8HUhqfQaLouzryejOMxziEtETbFOhkPr8BEmL2lumUzzquSC2awU1s6Yi5y4tAITp5oJkTBhMDFkpMVsZ6LpG9iuF3X1FgjHLvLSUJbTCuU1K2c0c8blHJhISxaB2Px3qgzNznHmxo3qBT1MofIUKk955anbCJJO8nvb8OMRMp-8eXQCejnHgjnB1XTyRU2LaTE5_sZVGsFhz346gdTdnTrkHcHBxqBUcCYr5cCFRDJBumUddT87N4C5HV1XizXewxC9ZZxHsN8a4t-Hp9xFpTyPIPPm9Oh1qdPxGV69-1fB9_As9eNDkLI6gO1mua4-OBDXmEO_Pf8AJZYyrw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9NAEB2hVnxcChRKDaUsEuLmKPbuetdHSmsCNDlULeltZTteCbVyUOJIhRM_gd_IL2Gf7Ri56qFC3CzFY2snM7Nv34xniN5o7eIiz2K_sDr3hYt_fja03Bd8JjJhdcpnoAbGk2h0Jj6dy_N2HBC-hWn6Q3SEGzyjjtdwcBDS171c-O6Ag3MeOD2uhvHAAcpNpOvgpYcnXS8p7Gtx05MzBOES9Mt6bnxSb6_ahNqvUDuZLp36bDP34iZg2se59UaVPKTL9RKb-pSLwarKBvmPa90f_5MOHtFWC2jZu8YCH9Odotyme-M2Zb9Nd1s-4gmdjCZJcMAweac2dva1ZG1b1yUDH8y-I_T8_vkLFd4VW9PCLFtVrJwz0H8lWxR4XZtXekpnydHp-5HfjnTwcwAnPw2GQ-sgEvKXPLZCh3GRSyVslCtrZ8IdnqS2CrnTVCgVCJUhN5Rpi4RnkPId2ijnZbFLTKKRvM64iHkB-VTkMx45-3IxTIW58Eit_zyTt_3OMXbj0vTOPcJAeQbKM7XyzJVHQSf5ren5cQuZt7V9dALp4gI1c0qa6eSDmSbTZHLwRZrQo_2eAXUCobs7dODbo721RZk2niyNwxcafIJ2y3rd_ewiAdI7aVnMV7hHAMBFUnr0rLHEvw8PpTuYytijqLanW6_LHI6PcPX8XwVf0f3R6fjYHH-cfH5BD8J6mggYrD3aqBar4qXDdFW2X_vqH15rNss
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NTtwwEB5VoKJegNK_UKBGqnrLahPbsXMshXRb2Aih0uVmxUksVVtl0W5Wgp76CH3GPkk9iTdVEAdU9RZpM4k8Ox5_881kBuCtlNYvUh37pZG5z6z_8_XQUJ_RgmlmZEYLpAbGaTS6ZJ-v-JWrf8JvYdr-EB3hhjuj8de4wa8Lc3eTM9_GNxjmIaVHxTAeWDy5ziIbbCFAuuhaSeGxFrctOUPkW4J-Vc-9T-odVeuo9RssncwWVnumHXtxHy7tw9zmnEq2YLpaYVueMh0saz3If9xp_vh_VLANmw7Okvet_T2FR2W1Axtjl7DfgceOjXgGF6M0CY4Izt1pTJ18q4hr6rogyAaTW3Q8v3_-wvrumqxIYaKXNalmBMm_isxLfJ3LKj2Hy-Tky4eR7wY6-DnCJj8LhkNjARJmL2lsmAzjMueCmSgXxhTMhk5cGoGZ04wJETChMTOkpcF0Z5DRF7BWzaryFRCObeSlpiymJcpnLC9oZK3LejAR5swDsfrvVO66nePQje-qF_UwhcpTqDzVKE_deBB0ktdtx48HyLxrzKMTyOZTrJgTXE3Sj2qSTJL06CtXoQcHPfvpBEJ7d2ihtwd7K4NSzpsslEUXEtkEaZd12P1s_QAmd7KqnC3xHobwLeLcg5etIf59eMhtWMpjD6LGnB68LnU8PsGr3X8VfAMb58eJOvuUnr6GJ2EzSgTpqz1Yq-fLct8CulofNDv1D29JNXo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HNF1B+deletions+in+patients+with+young-onset+diabetes+but+no+known+renal+disease&rft.jtitle=Diabetic+medicine&rft.au=EDGHILL%2C+E.+L&rft.au=STALS%2C+K&rft.au=ORAM%2C+R.+A&rft.au=SHEPHERD%2C+M.+H&rft.date=2013&rft.pub=Blackwell&rft.issn=0742-3071&rft.volume=30&rft.issue=1&rft.spage=114&rft.epage=117&rft_id=info:doi/10.1111%2Fj.1464-5491.2012.03709.x&rft.externalDBID=n%2Fa&rft.externalDocID=26732533
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0742-3071&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0742-3071&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0742-3071&client=summon